<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Stockholm_withbootstrap skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Stockholm/withbootstrap</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="page-wrapper"><CENTER><DIV id="header-wrapper"><DIV id="header" class="container"><NAV id="nav"><DIV class="title noselect">iGEM STOCKHOLM</DIV><UL><LI><A class="icon-home" href="https://2015.igem.org/Team:Stockholm"><SPAN>Home</SPAN></A></LI><LI><A class="icon-users" href="https://2015.igem.org/Team:Stockholm/Team"><SPAN>Team</SPAN></A></LI><LI><A class="icon-lab" href="https://2015.igem.org/Team:Stockholm/Description"><SPAN>Project</SPAN></A></LI><LI><A class="icon-clipboard" href="https://2015.igem.org/Team:Stockholm/Results"><SPAN>Results</SPAN></A></LI><LI><A class="icon-bubbles2" href="https://2015.igem.org/Team:Stockholm/Practices"><SPAN>Practices</SPAN></A></LI><LI><A class="icon-earth" href="https://2015.igem.org/Team:Stockholm/Collaborations"><SPAN>Collaborations</SPAN></A></LI><LI><A class="icon-gift" href="https://2015.igem.org/Team:Stockholm/Attributions"><SPAN>Attributions</SPAN></A></LI></UL></NAV></DIV></DIV></CENTER></DIV><DIV class="container-fluid content-container"><H2>ABBBA: Affibody-Based Bacterial Biomarker Assay </H2><P>Early diagnosis is important for patient prognosis. As a rule of thumb, the earlier a disease is diagnosed, the better the odds for recovery. Studies show that treatment for many different diseases (e.g. cancer) are more efficient when therapy is started at an early stage.  Yet, reliable, sensitive and easily applicable diagnostic tools are still lacking.</P><P>iGEM Stockholm 2015, consisting of students from Karolinska Institutet and the Royal Institute of Technology KTH, is developing a novel technique to measure even small amounts of disease biomarker in body fluids. It's an &quot;Affibody-Based Bacterial Biomarker Assay&quot;, and we call it ABBBA.</P></DIV></DIV></DIV></DIV></DIV></BODY></HTML>